Correction first posted 30 August 2026; figures rebuilt 20 October 2026. The pharmacy price table this page used to show was generated for a low-cost generic and was wrong for this medication, and it was withdrawn under that correction. There is no FDA-approved generic semaglutide in the United States, so a “generic” cash price for it does not exist. Every figure now on this page comes from a named, dated source in the table below: CMS NADAC, the FDA label, Novo Nordisk's published offers and CMS. Editorial review completed 20 October 2026.
Drugs

Semaglutide (Wegovy) price 2026: what a carton costs and the cheaper routes

Updated October 2026 4 min read

Reviewed by RxGrab Editorial, RxGrab Editorial Team

The estimated prices that were here have been withdrawn. They were generated for a low-cost generic and applied to a medication that has none. There is no FDA-approved generic semaglutide in the United States, so no “generic” cash price exists to quote. FDA's Orange Book lists the semaglutide compound patent (US 8,129,343) as expiring on 5 December 2031, with further listed patents on the product and its uses running to 17 February 2041 (Orange Book data files, October 2026 edition, read 20 October 2026). A listed patent date is not a promise of when a generic will launch. For an accurate account of what this costs without insurance, see Ozempic cost without insurance.
GLP-1 essentials

Gear GLP-1 users buy most

As an Amazon Associate I earn from qualifying purchases.

Federal data puts the wholesale side of this in plain view: Wegovy injection costs a pharmacy a median of $653.0446 per mL to acquire, across the 5 national drug codes CMS prices it under per mL (CMS NADAC, release of 14 October 2026). That price per mL is not the same for every pen, and the reason is pen size, not pharmacy: from the cheapest tenth of listings to the dearest it runs from $435.53 to $653.29 per mL, a ratio of 1.5, which is exactly the ratio between the 0.75 mL pens for the 1.7 mg and 2.4 mg doses and the 0.5 mL pens for the lower doses. Acquisition cost is not the pharmacy’s profit; the counter price also carries dispensing and overhead. Wegovy is approved for chronic weight management and to lower the risk of heart attack, stroke and cardiovascular death in adults with established cardiovascular disease and obesity or overweight (FDA label).

If you are paying out of pocket, the route you buy through matters more than the pharmacy. The CMS figure above is the injection priced per mL, and Wegovy is one single-dose pen a week (FDA label). The 0.25 mg, 0.5 mg and 1 mg pens each hold 0.5 mL, so at the median above one of those pens costs a pharmacy about $326.52 to acquire (0.5 x $653.0446), and a carton of four pens, four weeks of treatment, about $1,306.09 (2 mL in all, 2 x $653.0446), before any dispensing fee or margin. The 1.7 mg and 2.4 mg pens hold 0.75 mL at the lower price per mL above, which comes to about the same per pen ($326.65, 0.75 x $435.53). Wegovy is now also sold as a once-daily tablet, which CMS prices separately; the figures on this page are for the injection. The cheapest-to-dearest pharmacy spread that used to appear in this paragraph came from the withdrawn price table and is no longer shown.

RxGrab's Pharmacy Price Finder covers the programmes that publish cash prices: Walmart's list, Mark Cuban Cost Plus Drugs and Amazon RxPass. None of them lists semaglutide (programme matrix, verified 13 October 2026), so for Wegovy the published prices are the maker's own offers and the federal figures in the table below.

Published Wegovy prices and routes (October 2026)

Price chart withdrawn, see the notice above.

The estimated pharmacy table that was here is withdrawn. The table below lists only prices a source publishes for Wegovy, each dated.

RouteWho it is forPublished priceSource
Retail pharmacy acquisition cost, four-pen carton of 0.5 mL pens (0.25 mg, 0.5 mg or 1 mg)The floor under any retail cash quote$1,306.09 (2 mL x $653.0446 per mL); about $326.52 a penCMS NADAC, release of 14 October 2026
NovoCare Pharmacy self-pay, 0.25 mg to 2.4 mgNo insurance, or buying outside insurance$349 a month (one box of four pens); new patients pay $199 for each of the first two months of 0.25 mg and 0.5 mg, through 31 December 2026wegovy.com, read 20 October 2026
NovoCare Pharmacy self-pay, Wegovy HD 7.2 mgNo insurance, or buying outside insurance$399 a monthwegovy.com, read 20 October 2026
Wegovy savings cardCommercial insurance; government beneficiaries excludedAs little as $25 a month; savings capped at $100 a month (one month is one box of four pens)wegovy.com, read 20 October 2026
Medicare GLP-1 BridgeEligible Medicare Part D enrollees, with prior authorization, on criteria set by CMS$50 a month for any dose of the pen or tablet, 1 July 2026 to 31 December 2027wegovy.com, read 20 October 2026
Medicare negotiated price, from 1 January 2027What Part D plans pay the maker; not your copay$274 for a 30-day supply of semaglutide, against a $959 list priceCMS 2027 fact sheet

Every figure in that table is published by the source named beside it and dated. RxGrab has not measured a discount card price for Wegovy, so none is quoted here: a card price is set pharmacy by pharmacy and changes often. Our GoodRx and SingleCare comparison explains how those cards work.

Why Semaglutide prices vary so much

Pharmacy pricing is not standardized. Each pharmacy sets its own dispensing fee and markup and runs its own discount programmes. For Wegovy that is most of the story: as the CMS figures above show, pharmacies acquire each pen at close to one price, so a warehouse pharmacy such as Costco and a chain such as CVS or Walgreens can differ only by what they add on top.

For Semaglutide specifically, there is no FDA-approved generic in the United States, so no generic competition holds the price down. The maker sets the price, and what differs between pharmacies is the fee and margin added on top of it.

How to get Semaglutide even cheaper

For a brand with no generic, the route you buy through moves the price far more than the pharmacy you pick. These are the published routes, with their terms as the issuer states them:

The team at Health Britannica also covers evidence-based supplement alternatives that may complement your prescription regimen.

Should you use insurance or pay cash for Semaglutide?

This depends on your plan. If you have a high-deductible plan and have not met your deductible yet, you may be paying the plan's full negotiated price for each box. Compare that against the self-pay price above before the first fill, and ask NovoCare whether a self-pay purchase counts toward your deductible; RxGrab has not verified Novo Nordisk's terms on that for Wegovy.

We break this decision down fully in our guide: insurance vs cash price for prescriptions.

If you are a freelancer or self-employed, you may be able to deduct prescription costs as a medical expense. The team at CeoCult covers this in detail for 1099 workers.

Price alerts for Semaglutide are not live yet

Join the list and we will only email when they are. Nothing is being sent yet.

Frequently asked questions about Semaglutide pricing

What is the cheapest pharmacy for Semaglutide?

There is no FDA-approved generic semaglutide in the United States, so no discount pharmacy sells a cheaper generic. The lowest published cash price is Novo Nordisk's own self-pay offer through NovoCare Pharmacy: $349 a month for any dose from 0.25 mg to 2.4 mg, one box of four pens, with $199 for each of the first two months of 0.25 mg and 0.5 mg for new patients through 31 December 2026 (wegovy.com, read 20 October 2026). RxGrab's Pharmacy Price Finder does not list semaglutide, because none of the cash-price programmes it covers sells it.

Is there a generic version of Wegovy?

No, Wegovy (Semaglutide) does not currently have a generic equivalent available in the US. This is why prices remain high across all pharmacies.

Can I use a discount card for Semaglutide?

You can ask, but RxGrab has not measured a discount-card price for Wegovy from cards such as GoodRx or SingleCare, so this page does not quote a saving. The published lower prices are the maker's own: as little as $25 a month with commercial coverage (savings capped at $100 a month), or NovoCare Pharmacy self-pay from $349 a month (wegovy.com, read 20 October 2026). Federal law since 2018 (the Patient Right to Know Drug Prices Act and the Know the Lowest Price Act) bars contracts that stop a pharmacist telling you when paying cash is cheaper than your copay; it does not oblige the pharmacist to raise it, so ask.